CPA Applauds Cassidy, Whitehouse Bill to Close Customs Loophole, Strengthen American Manufacturers

CPA Applauds Cassidy, Whitehouse Bill to Close Customs Loophole, Strengthen American Manufacturers

CPA strongly supports Senator Cassidy and Whitehouse’s Last Sale Valuation Act because it closes a long-standing loophole that has allowed multinational importers to artificially understate the value of goods entering the United States.

Import Alert: India Drug Maker Recalls Cholesterol Meds Due To Manufacturing Defects

Import Alert: India Drug Maker Recalls Cholesterol Meds Due To Manufacturing Defects

Zydus Pharmaceuticals, one of India’s largest generic drug makers, recalled over 22,000 bottles of a cholesterol medication on Dec. 30, 2025. AvKare, a Tennessee-based pharmaceuticals distribution company that relies on imports, recalled around 7,900 cartons of Rosuvastatin, a widely used generic statin, a day later.

CPA Applauds Clarios, Responsible Battery Coalition Member Company, for Leadership in Sustainable, Secure Battery Supply Chains

CPA Applauds Clarios, Responsible Battery Coalition Member Company, for Leadership in Sustainable, Secure Battery Supply Chains

As highlighted in the Oval Office at the White House this week, Clarios played a part in the launch of ‘Project Vault,’ a major initiative to strengthen U.S. critical minerals security and safeguard American battery supply chains from global disruptions.

Senate Committee: Why Can’t We Label Where Pharmaceuticals Come From?

Senate Committee: Why Can’t We Label Where Pharmaceuticals Come From?

Clothes are labeled. Most food is labeled. Even your car has its manufacturing country of origin stamped onto the door panel. Pharmaceuticals on the other hand, one of the biggest import items and certainly one most critical to our daily health safety and security, usually do not come with any labels at all.

Who is Really Paying for Trump’s Tariffs?

Who is Really Paying for Trump’s Tariffs?

Few economic policies generate as much conversation as tariffs. Supporters see them as a way to rebuild domestic industry and rebalance supply chains. Critics argue they are little more than a tax on American consumers. For years, economists have tried to settle the question of who actually pays – and they have not all come to the same conclusion.

Why the 2025 Trade Deficit Might Not be as Bad as it Looks

Why the 2025 Trade Deficit Might Not be as Bad as it Looks

Once year-ending 2025 trade data is released in February, we will be looking at another $1 trillion deficit. Assuming the monthly goods deficit for November and December looks like the low October goods deficit of $58.5 billion, the U.S. will record a minimum $1.17 trillion goods gap for 2025, the second largest trade deficit since 2024’s $1.2 trillion barnstormer.

CPA Calls on Trump Administration to Prioritize Metal Fabricators in Ongoing Trade Actions

CPA Calls on Trump Administration to Prioritize Metal Fabricators in Ongoing Trade Actions

To trade away aluminum and steel workers’ home market in exchange for padding Big Tech’s bottom line overseas is immoral and wrong. The Section 232 actions on aluminum and steel should be singularly focused on rebuilding domestic output across the supply chains, not used as leverage to help Google and Meta become even more profitable.